
MC4033
CAS No. 28532-21-0
MC4033( —— )
Catalog No. M37143 CAS No. 28532-21-0
MC4033 is a selective lysine acetyltransferase 8 (KAT8) inhibitor (IC50: 12.1 μM) with anticancer effects, induces apoptosis, and can be used for the study of non-small cell lung cancer.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 47 | Get Quote |
![]() ![]() |
5MG | 67 | Get Quote |
![]() ![]() |
10MG | 107 | Get Quote |
![]() ![]() |
25MG | 211 | Get Quote |
![]() ![]() |
50MG | 342 | Get Quote |
![]() ![]() |
100MG | 536 | Get Quote |
![]() ![]() |
500MG | 1125 | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameMC4033
-
NoteResearch use only, not for human use.
-
Brief DescriptionMC4033 is a selective lysine acetyltransferase 8 (KAT8) inhibitor (IC50: 12.1 μM) with anticancer effects, induces apoptosis, and can be used for the study of non-small cell lung cancer.
-
DescriptionMC4033 shows IC50s of 39.4 μM, 52.1 μM, 41 μM and 30.1 μM in HCT116, H1299, A549 and U937, respectively.MC4033 (25, 50, 100, and 200 μM, 72 h) reduces the level of H4K16Ac in HT29 cells, suggesting its ability to inhibit KAT8 in cells.
-
In VitroCell Proliferation AssayCell Line:HT29, HCT116, HeLa, H1299, A549, H460, MCF7, U937, and U251 cellsConcentration:10, 25, 50, and 100 μMIncubation Time:72 hResult:Displayed dose-dependent antiproliferative effects in HCT116, H1299, A549, and U937 cell lines.The inhibition rate of cell proliferation was 70% at 50 μM and >80% at 100 μM in U937 cells.Cell Cycle AnalysisCell Line:HT29, HCT116, and HeLa cells Concentration:50 μM and 100 μM Incubation Time:72 h Result:Propidium iodide (PI) staining showed a slight increase in the percentage of cells with DNA hypodiploid peak, indicative of apoptosis.RT-PCR Cell Line:HCT116 cells Concentration: 100 μM Incubation Time:48h Result:Reduced the mRNA levels of oncogenes UCP2. Immunofluorescence Cell Line: HT29 cells Concentration:50 μM Incubation Time:24 h Result:Reduced H4K16Ac signal intensity by 80%.Western Blot Analysis Cell Line:HCT116 cells Concentration:0,10, 25, 50,100 μM Incubation Time:48 h Result:Showed that the altered ratio of LC3-II/-I and the regulation of p62 autophagy markers indicated the activation of autophagy in HCT116 cells.Apoptosis Analysis Cell Line:HCT116 cells Concentration:100 μM or 10 μM (MC4033/CQ) Incubation Time:72 h Result:Showed that exposure of HCT116 cells to CQ increased the apoptotic effect of KAT8i.
-
In Vivo——
-
Synonyms——
-
PathwayApoptosis
-
TargetApoptosis
-
RecptorApoptosis | Histone Acetyltransferase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number28532-21-0
-
Formula Weight295.29
-
Molecular FormulaC16H13N3O3
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 25 mg/mL (84.66 mM; Ultrasonic )
-
SMILESO=C(O)C1=CC=C(C=C1)N2N=C(C(=CC3=CC=CN3)C2=O)C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Fiorentino F, et al. First-in-Class Selective Inhibitors of the Lysine Acetyltransferase KAT8. J Med Chem. 2023 May 25;66(10):6591-6616?
molnova catalog



related products
-
Pipobroman
Pipobroman is an anti-cancer drug that probably acts as an alkylating agent.
-
SF5
SF5 is an inhibitor of the apoptosis pathway through JNK-p53-caspase apoptotic cascade.
-
KS106
KS106 is a selective and potent ALDH inhibitor with antiproliferative and anticancer activity, inhibits ALDH1A1, ALDH2, and ALDH3A1 with IC50 of 334, 2137, and 360 nM, respectively.